Swiss Primary Sclerosing Cholangitis Cohort Study
Trial statusRecruiting
Trial phaseNot listed
Trial typeObservational
Biological sexAll
AgeNot listed
SponsorFondazione Epatocentro Ticino
About this trial
Research project in which biological material is sampled and health-related personal data is further used and collected.
Coded data are used.
Eligibility criteria
This trial does not accept healthy volunteersQualifiers
Patients diagnosed with PSC according to established criteria (European Association for the Study of the Liver. EASL Clinical Practice Guidelines: management of cholestatic liver diseases) of any age. Patients not fulfilling such criteria but still diagnosed with PSC in a hepatology referral centre can be included
patients living in Switzerland
Disqualifiers
N/A
Trial population
PSC patients living in Switzerland of any age Patients diagnosed with PSC according to established criteria (European Association for the Study of the Liver. EASL Clinical Practice Guidelines: management of cholestatic liver diseases). Only patients living in Switzerland are enrolled. Enrollment of minors is possible upon consent of legal guardian
Trial design
Design model
Cohort
Time perspective
Prospective
Treatments tested in this trial
Not listed
Trial groups
No trial groups listed
Trial outcomes
Primary outcomes
1
Disease course
Observing disease course
Time frame
3 years2
Disease features
Observing disease features in Swiss population and see if they are similar to other countries'
Time frame
3 years3
Response to treatment
Observing response to treatment
Time frame
3 years4
Overall survival
Observing overall survival
Time frame
3 yearsSponsors and contacts
Click on the lead sponsor to view all of their trials.
Source ClinicalTrials.gov